Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • usfda

    Tag: usfda

    You Searched For "usfda"
    Alembic Pharma clears USFDA inspection at oncology unit in Panelav

    Alembic Pharma clears USFDA inspection at oncology unit in Panelav

    Farhat Nasim29 Jun 2019 10:02 AM IST
    This was a first scheduled inspection and Alembic Pharma passed the inspection without any Form 483 Observation.New Delhi: Alembic Pharmaceuticals...
    Dr Reddys launches generic version of Tobi in US market

    Dr Reddys launches generic version of Tobi in US market

    Farhat Nasim26 Jun 2019 3:07 PM IST
    The product is a therapeutic equivalent generic version of TOBI (tobramycin) Inhalation Solution, approved by the U.S. Food and Drug Administration...
    Alembic Pharma gets USFDA nod for generic version of Tamiflu capsules

    Alembic Pharma gets USFDA nod for generic version of Tamiflu capsules

    Farhat Nasim25 Jun 2019 11:54 AM IST
    The approved product, Oseltamivir Phosphate capsule is therapeutically equivalent to the reference listed drug (RLD), Tamiflu Capsules of Hoffman-La...
    Dr Reddys gets two USFDA observations for Vizag plants

    Dr Reddys gets two USFDA observations for Vizag plants

    Farhat Nasim24 Jun 2019 11:09 AM IST
    Hyderabad: City-based Dr Reddy's Laboratories (Dr Reddys/ DRL) has reportedly fallen under the US health regulator's scanner. The company has been...
    Cadila Healthcare gets EIR report on Ahmedabad SEZ facility

    Cadila Healthcare gets EIR report on Ahmedabad SEZ facility

    Medical Dialogues Bureau18 Jun 2019 1:57 PM IST
    New Delhi: Drug firm Cadila Healthcare Monday said it has received establishment inspection report from the US health regulator with voluntary action...
    Roche gets USFDA nod for combo lymphoma treatment Polivy

    Roche gets USFDA nod for combo lymphoma treatment Polivy

    Medical Dialogues Bureau11 Jun 2019 9:30 AM IST
    Polivy was approved in combination with Roche's older drug Rituxan and a chemotherapy agent for adult patients with advanced diffuse large B-cell...
    Natco Pharma- Kothur facility gets 9 observations from USFDA

    Natco Pharma- Kothur facility gets 9 observations from USFDA

    Medical Dialogues Bureau7 Jun 2019 2:21 PM IST
    NEW DELHI: Natco Pharma Thursday said the US health regulator has made nine observations after the completion of inspection of its Kothur formulation...
    Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension

    Natco Pharma files ANDA for generic version of Bosentan tablets for oral suspension

    Farhat Nasim5 Jun 2019 10:00 AM IST
    Bosentan 32 mg tablets are sold by Actelion Pharmaceuticals US, Inc. (acquired by Johnson and Johnson) under the brand name Tracleer.Hyderabad:...
    Cadila Healthcare gets 11 USFDA observations for St Louis facilities

    Cadila Healthcare gets 11 USFDA observations for St Louis facilities

    Farhat Nasim3 Jun 2019 5:23 PM IST
    The United States Food and Drug Administration (USFDA) inspected the manufacturing facilities of Nesher Pharmaceuticals (USA) LLC located at St Louis,...
    Cadila Healthcare posts Q4 net profit of Rs 460 crore

    Cadila Healthcare posts Q4 net profit of Rs 460 crore

    Medical Dialogues Bureau30 May 2019 9:15 AM IST
    The consolidated financial statements for the quarter and the year ended March 31, 2019, including the operations of Heinz India Pvt Ltd (HIPL) for...
    Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver

    Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver

    Farhat Nasim28 May 2019 4:21 PM IST
    New Delhi: Apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has been recommended by the Techincal Committee to granted...
    Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules

    Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules

    Farhat Nasim28 May 2019 10:00 AM IST
    The approved product, Methylphenidate Hydrochloride extended-release capsules, is bioequivalent to the reference listed drug product (RLD), Ritalin LA...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok